专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20090102356A1 NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND 有权
标题翻译：具有电子传输和/或空穴阻塞性能的新有机化合物及其使用和包含化合物的OLED
公开(公告)号：US20090102356A1
公开(公告)日：2009-04-23
申请号：US12252153
申请日：2008-10-15
申请人： PengFei WANG , Na LI , Weimin LIU , Shuit-Tong LEE , Chun-Sing Lee
发明人： PengFei WANG , Na LI , Weimin LIU , Shuit-Tong LEE , Chun-Sing Lee
IPC分类号： H01L51/50 , H01J1/63 , C07D401/10 , C07D405/14
CPC分类号： C07D405/14 , C07D213/53 , C07D213/57 , C07D213/80 , C07D213/85 , H01L51/0067 , H01L51/5048 , H01L2251/308 , Y10S428/917
摘要： Disclosed herein are several organic compounds having electron-transporting and/or hole-blocking performance and their preparation method and use and the OLEDs comprising the organic compound. The organic compounds exhibit high ionization potential (IP), electron affinity (Ea), glass transition temperature (Tg) and high electron mobility, and are a kind of good electron-transporting material with good hole-blocking ability. The devices comprising these compounds as one of the emitting layer, electron-transporting layer (ETL) and hole-blocking layer (HBL) show improved efficiency and better color purity.
摘要翻译：本文公开了具有电子传输和/或空穴阻断性能的几种有机化合物及其制备方法和用途以及包含有机化合物的OLED。有机化合物表现出高电离电位（IP），电子亲和力（Ea），玻璃化转变温度（Tg）和高电子迁移率，是一种具有良好的空穴阻挡能力的良好的电子传输材料。包含这些化合物作为发光层，电子传输层（ETL）和空穴阻挡层（HBL）之一的器件显示出提高的效率和更好的色纯度。

2. 发明申请

US20120220561A1 OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：氧氟沙星生产的氧化氮抑制剂
公开(公告)号：US20120220561A1
公开(公告)日：2012-08-30
申请号：US13208582
申请日：2011-08-12
申请人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , John D. HUBER , Ho Yin LO , Pui Leng LOKE , Weimin LIU , Tina Marie MORWICK , Alan OLAGUE , Doris RIETHER , Heather TYE , Lifen WU , Renee M. ZINDELL
发明人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , John D. HUBER , Ho Yin LO , Pui Leng LOKE , Weimin LIU , Tina Marie MORWICK , Alan OLAGUE , Doris RIETHER , Heather TYE , Lifen WU , Renee M. ZINDELL
IPC分类号： A61K31/506 , A61P29/00 , A61P37/08 , A61P11/00 , A61P13/12 , A61P35/00 , A61P9/10 , C07D413/14 , A61K31/497 , C07D413/10 , A61K31/5377 , C07D417/14 , A61K31/541 , C07D471/08 , C07D498/04 , A61K31/5383 , A61K31/437 , A61K31/4439 , C07D487/04 , A61K31/4985 , A61K31/4545 , A61K31/513 , A61P9/00
CPC分类号： C07D413/14 , C07D413/10 , C07D417/14 , C07D471/04 , C07D498/04
摘要： The present invention relates to compound of formula (I): or pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐，其中R 1 -R 5如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

3. 发明申请

US20120214787A1 OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：氧氟沙星生产的氧化氮抑制剂
公开(公告)号：US20120214787A1
公开(公告)日：2012-08-23
申请号：US13215654
申请日：2011-08-23
申请人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , Jonathon Alan DINES , John D. HUBER , Weimin LIU , Ho Yin LO , Pui Leng LOKE , Tina Marie MORWICK , Peter Allen NEMOTO , Alan OLAGUE , Doris RIETHER , Heather Tye , Lifen WU , Renee M. ZINDELL
发明人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , Jonathon Alan DINES , John D. HUBER , Weimin LIU , Ho Yin LO , Pui Leng LOKE , Tina Marie MORWICK , Peter Allen NEMOTO , Alan OLAGUE , Doris RIETHER , Heather Tye , Lifen WU , Renee M. ZINDELL
IPC分类号： C07D413/14 , A61K31/506 , A61K31/496 , A61K31/501 , A61K31/497 , A61P13/12 , C07D487/04 , A61P9/00 , A61P9/10 , A61P37/08 , A61P35/04 , C07D413/10 , A61K31/5355
CPC分类号： C07D413/14 , A61K31/4245 , C07D413/10 , C07D417/14
摘要： The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其中R 1 -R 5如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

4. 发明申请

US20120277227A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：紫杉醇生产的苯并咪唑抑制剂
公开(公告)号：US20120277227A1
公开(公告)日：2012-11-01
申请号：US13281687
申请日：2011-10-26
申请人： Stephane DE LOMBAERT , Weimin LIU , Ho Yin LO , Peter Allen NEMOTO
发明人： Stephane DE LOMBAERT , Weimin LIU , Ho Yin LO , Peter Allen NEMOTO
IPC分类号： A61K31/506 , A61P29/00 , A61P37/08 , A61P11/00 , A61K31/5377 , A61P35/00 , A61P9/10 , C07D401/14 , C07D413/14 , A61P9/00 , A61P13/12
CPC分类号： C07D401/14
摘要： The present invention relates to compounds of formula (IA), (IB) and (IC): and pharmaceutically acceptable salts thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（IA），（IB）和（IC）的化合物及其药学上可接受的盐，其中R 1 -R 7如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

5. 发明申请

US20120245162A1 OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：氧氟沙星生产的氧化氮抑制剂
公开(公告)号：US20120245162A1
公开(公告)日：2012-09-27
申请号：US13237106
申请日：2011-09-20
申请人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , John D. HUBER , Weimin LIU , Ho Yin LO , Pui Leng LOKE , Doris RIETHER , Heather TYE , Lifen WU , Renee M. ZINDELL
发明人： Alessandra BARTOLOZZI , Todd BOSANAC , Zhidong CHEN , Stephane DE LOMBAERT , John D. HUBER , Weimin LIU , Ho Yin LO , Pui Leng LOKE , Doris RIETHER , Heather TYE , Lifen WU , Renee M. ZINDELL
IPC分类号： A61K31/506 , A61P29/00 , A61P37/08 , A61P11/00 , A61P13/12 , A61P35/00 , A61P9/10 , C07D413/14 , A61K31/444 , A61K31/5377 , C07D498/04 , A61K31/5383 , C07D487/04 , A61K31/519 , A61K31/4985 , A61P9/00
CPC分类号： C07D413/14
摘要： The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其中R 1 -R 5如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体

6. 发明申请

US20120277226A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：紫杉醇生产的苯并咪唑抑制剂
公开(公告)号：US20120277226A1
公开(公告)日：2012-11-01
申请号：US13281685
申请日：2011-10-26
申请人： Zhidong CHEN , Stephane DE LOMBAERT , Jonathon Alan DINES , Weimin LIU , Ho Yin LO , Pui Leng LOKE
发明人： Zhidong CHEN , Stephane DE LOMBAERT , Jonathon Alan DINES , Weimin LIU , Ho Yin LO , Pui Leng LOKE
IPC分类号： A61K31/506 , A61P29/00 , A61P37/08 , A61P11/00 , A61P13/12 , A61P35/00 , A61P9/10 , C07D403/10 , C07D405/14 , C07D401/14 , C07D413/14 , A61K31/5377 , C07D401/10 , A61K31/4439 , C07D403/14 , A61P9/00
CPC分类号： C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14
摘要： The present invention relates to compounds of formula (IA) and (IB): and pharmaceutically acceptable salts thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（IA）和（IB）的化合物及其药学上可接受的盐，其中R 1 -R 7如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

7. 发明申请

US20090190562A1 HRPD NETWORK ACCESS AUTHENTICATION METHOD BASED ON CAVE ALGORITHM 有权
标题翻译：基于CAVE算法的HRPD网络访问认证方法
公开(公告)号：US20090190562A1
公开(公告)日：2009-07-30
申请号：US12421986
申请日：2009-04-10
申请人： Weimin LIU
发明人： Weimin LIU
IPC分类号： H04B7/216
CPC分类号： H04W12/08 , H04L63/0428 , H04L63/08 , H04L63/0853 , H04W12/06
摘要： A HRPD network access authentication method based on CAVE algorithm is provided. An AT (Access Terminal) generates a random number “RAND” necessary for a calculation of an AUTH1 by using a “Random text” included in the CHAP Challenge message. A UIM (User Identity Module) card works out the AUTH1 by using the random number “RAND” and an SSD_A (Shared Secret Data A) in the UIM card. The AT carries the AUTH1 in a Result field of the CHAP Response message. An AN-AAA (Access Network-Authentication, Authorization, and Accounting) generates the random number “RAND” necessary for the calculation of an AUTH2 by using a “Random text” included in a Radius Access Request message. The AN-AAA works out the AUTH2 by using the random number “RAND”. The two results AUTH1 and AUTH2 are compared. If the results are the same, the authentication on the AT passes. Otherwise, AT access is rejected.
摘要翻译：提供了基于CAVE算法的HRPD网络访问认证方法。 AT（接入终端）通过使用CHAP挑战消息中包含的“随机文本”生成AUTH1的计算所需的随机数“RAND”。 UIM（用户识别模块）卡通过在UIM卡中使用随机数“RAND”和一个SSD_A（共享秘密数据A）来处理AUTH1。 AT在CHAP响应消息的结果字段中携带AUTH1。 AN-AAA（接入网络认证，授权和计费）通过使用包含在Radius接入请求消息中的“随机文本”生成AUTH2计算所需的随机数“RAND”。 AN-AAA通过使用随机数“RAND”来编写AUTH2。比较两个结果AUTH1和AUTH2。如果结果相同，AT上的认证通过。否则AT访问被拒绝。

8. 发明申请

US20110301161A1 BENZIMIDAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION 有权
标题翻译：紫杉醇生产的苯并咪唑抑制剂
公开(公告)号：US20110301161A1
公开(公告)日：2011-12-08
申请号：US12957766
申请日：2010-12-01
申请人： Zhidong CHEN , Ming-Hong HAO , Weimin LIU , Ho-Yin LO , Pui Leng LOKE , Chuk Chui MAN , Tina Marie MORWICK , Peter Allen NEMOTO , Hidenori TAKAHASHI , Heather TYE , Lifen WU
发明人： Zhidong CHEN , Ming-Hong HAO , Weimin LIU , Ho-Yin LO , Pui Leng LOKE , Chuk Chui MAN , Tina Marie MORWICK , Peter Allen NEMOTO , Hidenori TAKAHASHI , Heather TYE , Lifen WU
IPC分类号： A61K31/506 , C07D471/04 , C07D401/14 , C07D413/14 , A61K31/437 , A61P35/00 , A61K31/5377 , A61K31/497 , A61P9/00 , A61P29/00 , A61P37/08 , A61P13/12 , C07D403/14 , A61K31/4439
CPC分类号： C07D471/04 , C07D401/12 , C07D403/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要： The present invention relates to compounds of formula (I): and pharmaceutically acceptable salt thereof, wherein R1-R7 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要翻译：本发明涉及式（I）化合物及其药学上可接受的盐，其中R 1 -R 7如本文所定义。本发明还涉及包含这些化合物的药物组合物，使用这些化合物治疗各种疾病和病症的方法，制备这些化合物的方法和可用于这些方法的中间体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式